Furthermore, the same analysis, done with hormone receptor status divided into estrogen-receptor positive or estrogen-receptor negative status, resulted in HR for breast cancer death 2.69 (95% CI 1.21–6.00) compared with BCT with HR 1.0. Here, NR4A1 is linked to breast carcinoma.